南方医科大学学报 ›› 2005, Vol. 25 ›› Issue (05): 531-534.

• • 上一篇    下一篇

幽门螺杆菌热休克蛋白60脂质体疫苗的制备及其免疫预防作用

黄文1, 白杨1, 王继德1, 武金宝1, 李国锋2, 张卫民1, 周殿元1   

  1. 1. 南方医科大学南方医院消化病研究所, 广东, 广州, 510515;
    2. 南方医科大学南方医院药学部, 广东, 广州, 510515
  • 出版日期:2005-05-20 发布日期:2005-05-20
  • 基金资助:
    收稿日期:2004-9-28。
    基金项目:国家自然科学基金(30170890)
    作者简介:黄文(1966- ),男,2003年毕业于第一军医大学,博士后,副教授,副主任医师,现工作单位:第二军医大学长海医院消化科,电话:021-25074838,E-mail:huangsh666@263.net

Preparation oral liposome-encapsulated recombinant Helicobacter pylori heat shock protein 60 vaccine for prevention of Hp infection

HUANG Wen1, BAI Yang1, WANG Ji-de1, WU Jin-bao1, LI Guo-feng2, ZHANG Wei-ming1, ZHOU Dian-yuan1   

  1. 1. 南方医科大学南方医院消化病研究所, 广东, 广州, 510515;
    2. 南方医科大学南方医院药学部, 广东, 广州, 510515
  • Online:2005-05-20 Published:2005-05-20

摘要: 目的 探讨制备脂质体包裹重组幽门螺杆菌(Hp)热休克蛋白60(Hsp60)口服疫苗的方法,并用Hp感染的小鼠模型评价其在预防Hp感染中的作用.方法 将PET-22(+)/Hsp60在BL21(DE3)大肠杆菌表达,Ni-NTA琼脂糖树脂纯化Hsp60重组蛋白,用薄膜分散法制备以卵磷脂和胆固醇为膜组分包裹的Hsp60重组蛋白口服疫苗,并用透射电镜测定其粒径.75只BALB/C小鼠分为5组,分别通过灌胃方法给予PBS、空白脂质体、Hsp60重组蛋白+霍乱霉素(CT)、脂质体包裹Hsp60重组蛋白、脂质体包裹Hsp60重组蛋白+CT,每周1次共次,末次攻击2周再用活Hp攻击3次,3周后处死小鼠,行胃组织快速尿素酶试验、Hp的定植半定量、炎症程度及其炎症活动度的评分.结果 可溶性表达产物占全菌总蛋白的27%,经纯化获得纯度为95%的重组蛋白,制备的脂质体粒径为(0.7±0.)μm.PBS组和空白脂质体组保护率均为0,而Hsp60重组蛋白+CT组、脂质体包裹Hsp60重组蛋白组、脂质体包裹Hsp60重组蛋白+CT组的保护率分别为73.3%、66.7%和86.7%,且均能使免疫小鼠胃粘膜Hp感染数目明显减少,炎症反应减轻.结论 口服脂质体能分地代替免疫佐剂,作为Hp疫苗的免疫佐剂,将具有广泛的应用前景.

Abstract: Objective To prepare oral liposome-encapsulated recombinant Helicobacter pylori (Hp) heat shock protein 60 (Hsp60) vaccine and investigate its effect against Hp infection in mice.Methods The recombinant vector PET-22(+)/Hsp60 was transformed into BL21(DE3) E.coli. The recombinant protein was purified with Ni-NTA agrose resin and the oral liposome-encapsulated vaccine was prepared with phosphatidyl choline and cholesterols using film method, with the size distribution of the folate liposomes measured by transimssion electronic microscopy. BALB/c mice were divided into 5 groups and immunized by intragastric administration of PBS, liposome, rHsp60 plus choleratoxin (CT), liposome-encapsulated rHsp60, and liposome-encapsulated rHsp60 plus CT, respectively, given once a week for 4 weeks. All the mice were challenged by Hp for 3 times within two weeks following the last immunization and sacrificed 3 weeks after the last challenge. Hp detection was performed by fast urease test. Semi-quantitative assessment of the bacterial colonization density observation of the inflammation severity and gastric histopathology were carried out. Results The soluble expression product accounted for 27% of the total bacterial protein. The purity of recombinant fusion protein was about 95% after purification. The mean size of the folate liposomes was 0.7±0.4 μm. PBS or liposome alone showed no immune-enhancing effect, and rHsp60 plus CT, liposome-encapsulated rHsp60 and liposome-encapsulated rHsp60 plus CT had the protective rates against Hp infection of 73.3%, 66.7% and 86.7%, respectively. The latter 3 preparations effected significantly reduced Hp infection and alleviated the inflammation in the gastric mucosa of the mice challenged with Hp.Conclusion The oral liposome may serve as a potential adjuvant for Hp vaccine in preventing Hp infection.

中图分类号: